Cryo-Cell International, Inc.
ASE: CCELLive Quote
📈 ZcoreAI Score
Our AI model analyzes Cryo-Cell International, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get CCEL Z-Score →About Cryo-Cell International, Inc.
Healthcare
Medical Care Facilities
Cryo-Cell International, Inc. engages in cord blood and cord tissue cryopreservation services in the United States. The company offers cellular processing and cryogenic storage for family use, primarily for collection and preservation of umbilical cord blood, and tissue stem cells; and cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. It is also involved in the manufacturing of PrepaCyte CB processing system units for processing umbilical cord blood stem cells. In addition, the company provides cold storage services to third-party pharmaceutical companies and medical institutions. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.
📊 Fundamental Analysis
Cryo-Cell International, Inc. demonstrates a profit margin of -7.7%, which is below the sector average, suggesting competitive pressure.
The company recently reported -2.3% revenue growth, which is negative, indicating a recent decline in revenue.
At a current price of $3.47, CCEL currently sits at the 21st percentile of its 52-week range (Range: $2.72 - $6.35).
🏥 Financial Health
🔴
Profit Margin
Weak
🔴
Revenue Growth
Weak
✅
Beta (Risk)
Low Volatility
Key Financials
Market Cap
$27.95M
Trailing P/E
--
Forward P/E
43.38
Beta (5Y)
0.63
52W High
$6.35
52W Low
$2.72
Avg Volume
13K
Day High
Day Low